Does AMLODIPINE\TELMISARTAN Cause Interstitial lung disease? 14 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 14 reports of Interstitial lung disease have been filed in association with AMLODIPINE\TELMISARTAN. This represents 2.9% of all adverse event reports for AMLODIPINE\TELMISARTAN.
14
Reports of Interstitial lung disease with AMLODIPINE\TELMISARTAN
2.9%
of all AMLODIPINE\TELMISARTAN reports
1
Deaths
2
Hospitalizations
How Dangerous Is Interstitial lung disease From AMLODIPINE\TELMISARTAN?
Of the 14 reports, 1 (7.1%) resulted in death, 2 (14.3%) required hospitalization, and 1 (7.1%) were considered life-threatening.
Is Interstitial lung disease Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for AMLODIPINE\TELMISARTAN. However, 14 reports have been filed with the FAERS database.
What Other Side Effects Does AMLODIPINE\TELMISARTAN Cause?
Hypotension (70)
Toxicity to various agents (66)
Balance disorder (60)
Depressed level of consciousness (60)
Pain (60)
Constipation (59)
Blood calcium decreased (57)
Fall (57)
Sedation complication (56)
Cognitive disorder (55)
What Other Drugs Cause Interstitial lung disease?
METHOTREXATE (3,049)
RITUXIMAB (2,458)
PEMBROLIZUMAB (2,113)
PREDNISONE (1,850)
CYCLOPHOSPHAMIDE (1,725)
NIVOLUMAB (1,538)
AMIODARONE (1,421)
DOXORUBICIN (1,352)
ETANERCEPT (1,267)
ADALIMUMAB (1,250)
Which AMLODIPINE\TELMISARTAN Alternatives Have Lower Interstitial lung disease Risk?
AMLODIPINE\TELMISARTAN vs AMLODIPINE\VALSARTAN
AMLODIPINE\TELMISARTAN vs AMMONIUM
AMLODIPINE\TELMISARTAN vs AMNESTEEM
AMLODIPINE\TELMISARTAN vs AMOXAPINE
AMLODIPINE\TELMISARTAN vs AMOXICILLIN